THE HYDRATION PHARMACEUTICALS COMPANY LIMITED (HPC.AX) Financial Forecast
Australia · Industrial & Consumer Products · AUD · Annual
Key financials
AUD
ROE
-137.51%
2025 (actual)
ROA
-79.59%
2025 (actual)
Gross Margin
55.18%
2025 (actual)
Net Margin
-115.74%
2025 (actual)
Total Assets
A$2,193,062.00
2025 (actual)
Net Income
-A$2,860,896.00
2025 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
AUD
Reported figures and Equlion model projections for the next 5 years.
ROE
+191.4 pt
Company
ROA
-639.2 pt
Company
Sector average (own scale)
Gross Margin
+2.9 pt
Company
Sector average
Net Margin
-326.2 pt
Company
Total Assets
-22.3%
Company
Net Income
-505.5%
Company
Sector average (own scale)
Detailed data
AUD
Amounts in AUD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for THE HYDRATION PHARMACEUTICALS COMPANY LIMITED? It covers the balance sheet, income statement, cash flow and Equlion model projections.